Viekira Pak Induced Fatal Lactic Acidosis: A Case Report of an Unusual Side Effect
Viekira Pak is a new direct-acting antiviral agent that has an excellent efficacy in treating patients with chronic HCV. FDA released a safety warning that Viekira Pak can cause serious liver injury mostly in patients with underlying advanced liver disease. We report the first case of fatal lactic a...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Case Reports in Hepatology |
Online Access: | http://dx.doi.org/10.1155/2016/8627139 |